Paul Budhan
Head of Franchise - Io Gi Oncology & Her2 Tumour Agnostic @阿斯利康
Signup · Get unlimited contacts
WORK HISTORY
Head of Franchise - Io Gi Oncology & Her2 Tumour Agnostic @阿斯利康
London, GB
o Led commercial strategy and launch readiness for a rapidly expanding GI cancer portfolio (BTC, HCC, OC & GC/GEJ), aligning cross-functional teams across Medical, Access, and Diagnostics to exceed brand and patient experience objectives.o Delivered industry-leading brand and franchise strategies, leveraging market insights, competitive intelligence, and scientific advancements to shape near- and long-term commercial success.o Drove P&L ownership and business performance, achieving phased budget targets through effective forecasting, financial stewardship, and brand contribution management across multiple indications.o Pioneered digital transformation projects, embedding innovative customer engagement strategies in collaboration with Business Excellence, IT, and field force teams.o Built and led a high-performing cross-functional team, mentoring future leaders and evolving capabilities to support a modern go-to-market model in a complex oncology ecosystem.o Acted as a key strategic connector between local, regional, and global stakeholders, aligning on shared goals and driving collaboration across internal teams and alliance partners.
EDUCATION
University of Exeter
BA (Hons), Accounting & Finance
The Chartered Institute of Management Accountants
ACMA CGMA, Managment Accounting
University of Reading
MSc, International Accounting & Consultancy
University of Warwick - Warwick Business School
Master of Business Administration (MBA)
SKILLS
ABOUT PAUL BUDHAN
A grounded leader with over 17 years of experience driving commercial success, strategic growth, and market expansion in the pharmaceutical industry. With expertise spanning finance, oncology, haematology, and business transformation, I have successfully scaled businesses, led market entries, and optimized P&L strategies across global organizations like AstraZeneca, Bayer, and AbbVie. Currently leading AstraZeneca’s GI Business Unit in the UK as a Head of Franchise, I have successfully launched and gained leadership in multiple GI and HER2 Tumour Agnostic indications as well as building and establishing this new Franchise. My expertise in cross-functional leadership and financial planning has helped transform underperforming brands, launch blockbuster therapies, and drive double-digit revenue growth. Passionate about commercial innovation, omnichannel marketing, and leadership development, I thrive on shaping the future of pharma while making a meaningful impact on patients’ lives. Let’s connect to discuss strategic leadership, market growth, and commercial excellence opportunities.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.